[HTML][HTML] Multicenter retrospective study of secukinumab drug survival in psoriasis patients in a daily practice setting: a long-term experience in Spain

E Daudén, GPG de Lima, S Armesto… - Dermatology and …, 2021 - Springer
Introduction There is limited and conflicting evidence over the real-world drug survival of
secukinumab (SEC) in patients with psoriasis, especially in the long term. Our objective was …

Multicenter retrospective study of secukinumab drug survival in psoriasis patients in a daily practice setting: A long-term experience in Spain

E Daudén, GPG de Lima, S Armesto, E Herrera-Acosta… - 2021 - lareferencia.info
There is limited and conflicting evidence over the real-world drug survival of secukinumab
(SEC) in patients with psoriasis, especially in the long term. Our objective was to analyze the …

[HTML][HTML] Multicenter Retrospective Study of Secukinumab Drug Survival in Psoriasis Patients in a Daily Practice Setting: A Long-Term Experience in Spain

E Daudén, GPG de Lima, S Armesto… - Dermatology and …, 2021 - ncbi.nlm.nih.gov
Methods Patients clinically diagnosed with plaque psoriasis and under treatment with
secukinumab (n= 384) in a daily practice setting were analyzed in a retrospective …

Multicenter Retrospective Study of Secukinumab Drug Survival in Psoriasis Patients in a Daily Practice Setting: A Long-Term Experience in Spain.

E Daudén, GPG de Lima, S Armesto… - Dermatology and …, 2021 - go.gale.com
Introduction There is limited and conflicting evidence over the real-world drug survival of
secukinumab (SEC) in patients with psoriasis, especially in the long term. Our objective was …

Multicenter Retrospective Study of Secukinumab Drug Survival in Psoriasis Patients in a Daily Practice Setting: A Long-Term Experience in Spain

E Daudén, GPG de Lima, S Armesto… - Dermatology and …, 2021 - pubmed.ncbi.nlm.nih.gov
Introduction There is limited and conflicting evidence over the real-world drug survival of
secukinumab (SEC) in patients with psoriasis, especially in the long term. Our objective was …

Multicenter Retrospective Study of Secukinumab Drug Survival in Psoriasis Patients in a Daily Practice Setting: A Long-Term Experience in Spain.

E Daudén, GPG de Lima, S Armesto… - Dermatology and …, 2021 - europepmc.org
Methods Patients clinically diagnosed with plaque psoriasis and under treatment with
secukinumab (n= 384) in a daily practice setting were analyzed in a retrospective …

[PDF][PDF] Multicenter Retrospective Study of Secukinumab Drug Survival in Psoriasis Patients in a Daily Practice Setting: A Long-Term Experience in Spain

DVEVR Rivera, PCA Martorell, F Ballesca… - Dermatol Ther …, 2021 - academia.edu
Multicenter Retrospective Study of Secukinumab Drug Survival in Psoriasis Patients in a Daily
Practice Setting: A Long-Term Expe Page 1 BRIEF REPORT Multicenter Retrospective Study of …

Multicenter Retrospective Study of Secukinumab Drug Survival in Psoriasis Patients in a Daily Practice Setting: A Long-Term Experience in Spain.

E Daudén, GPG de Lima, S Armesto… - Dermatology & …, 2021 - search.ebscohost.com
Introduction: There is limited and conflicting evidence over the real-world drug survival of
secukinumab (SEC) in patients with psoriasis, especially in the long term. Our objective was …

[引用][C] Multicenter Retrospective Study of Secukinumab Drug Survival in Psoriasis Patients in a Daily Practice Setting: A Long-Term Experience in Spain

E Daudén, GPG de Lima… - Dermatology and …, 2021 - produccioncientifica.ucm.es

[PDF][PDF] Multicenter Retrospective Study of Secukinumab Drug Survival in Psoriasis Patients in a Daily Practice Setting: A Long-Term Experience in Spain

DVEVR Rivera, PCA Martorell, F Ballesca… - Dermatol Ther …, 2021 - academia.edu
Multicenter Retrospective Study of Secukinumab Drug Survival in Psoriasis Patients in a Daily
Practice Setting: A Long-Term Expe Page 1 BRIEF REPORT Multicenter Retrospective Study of …